The Benefits of a Preoperative Anemia Management Program
Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to gain further insight into the comparative effectiveness of
treating patients, who are found to be anemic before their elective surgery, with a series of
weekly subcutaneous doses of a drug given before surgery, which stimulates the natural
production of red blood cells (a so-called erythropoietic stimulating agent [ESA]) along with
intravenous iron, in reducing the need for blood transfusions (donated by someone other than
the patient) during and after adult total hip arthroplasty (hip replacement surgery). The
effects of a Preoperative Anemia Management Program (PAMP) on the patient's quality of
recovery, health-related quality of life, fatigue, and rehabilitation pattern after surgery
will also be examined. A cost-effectiveness analysis will be performed to compare the cost of
these commercially available, FDA-approved medications versus the cost of transfused blood
Phase:
N/A
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Epoetin Alfa Ferric Compounds Ferric Oxide, Saccharated Iron